About the journal
Leukemia Research Reports is an open-access journal published by Elsevier in Netherlands, publishing in english. It is listed in DOAJ according to the sources read. Declared publication charge: 1,390 USD. Declared review time at DOAJ: 16 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- Elsevier
- ISSN
- 2213-0489
- Country
- Netherlands
- Languages
- english
- Access
- Open access
- Declared publication charge
- 1,390 USD
- Articles in DOAJ
- 503
- Declared review time
- 16 weeks
- Declared peer-review model
- peer_review
- Official website
- https://www.sciencedirect.com/journal/leukemia-research-reports
Index listings
- DOAJ · 2015-02-25
- Indexing
- DOAJ
- APC
- 1,390 USD
- Declared review time (DOAJ)
- 16 weeks — journal-declared only (not measured)
- Activity (OpenAlex)
- Active — latest works 2026
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Articles in DOAJ
503
Most recent article
5 months ago
Average review time (journal-declared via DOAJ)
16weeks
Works in OpenAlex
587
Last recorded publication year
2026
h-index
20
i10-index
80
From OpenAlex open data (CC0).
Editorial & policy12
- Last DOAJ review date
- 2026-04-27
- Added to DOAJ
- 2015-02-25
- Declared plagiarism screening
- Declared
- Other fees beyond APC
- No
- Declared digital preservation
- CLOCKSSPMCPortico
- Observed digital preservation (Keepers registry)— snapshot 2026-10-05
- CLOCKSSPortico
- Editorial board
- Official page ↗
- Norwegian register (HK-dir)— 2026
- Level 1 — approved scholarly channel
- Open references deposited at Crossref
- 82%
- ORCID iDs in current deposits
- 61%
- Deposits licence metadata at Crossref
- ✓
- APC waiver policy
- View policy
- Peer-review policy
- View policy
Identity & continuity2
- Source type
- journal
- NLM unique ID (PubMed)
- 101608906
Classification2
Subjects (DOAJ)
LCC codes
Subject areas
- Acute Myeloid Leukemia Research
- Acute Myeloid Leukemia Research
- Chronic Myeloid Leukemia Treatments
- Chronic Myeloid Leukemia Treatments
- Chronic Lymphocytic Leukemia Research
- Chronic Lymphocytic Leukemia Research
- Lymphoma Diagnosis and Treatment
- Lymphoma Diagnosis and Treatment
Show all subjects (50)
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Acute Lymphoblastic Leukemia research
- Acute Lymphoblastic Leukemia research
- Multiple Myeloma Research and Treatments
- Multiple Myeloma Research and Treatments
- Eosinophilic Disorders and Syndromes
- Eosinophilic Disorders and Syndromes
- Retinoids in leukemia and cellular processes
- Retinoids in leukemia and cellular processes
- Hematopoietic Stem Cell Transplantation
- Hematopoietic Stem Cell Transplantation
- Viral-associated cancers and disorders
- CAR-T cell therapy research
- Viral-associated cancers and disorders
- CNS Lymphoma Diagnosis and Treatment
- CNS Lymphoma Diagnosis and Treatment
- CAR-T cell therapy research
- Blood disorders and treatments
- Blood disorders and treatments
- Cutaneous lymphoproliferative disorders research
- Cutaneous lymphoproliferative disorders research
- Immunodeficiency and Autoimmune Disorders
- Immunodeficiency and Autoimmune Disorders
- Protein Degradation and Inhibitors
- Protein Degradation and Inhibitors
- Neutropenia and Cancer Infections
- Neutropenia and Cancer Infections
- Immune Cell Function and Interaction
- Immune Cell Function and Interaction
- Hemoglobinopathies and Related Disorders
- Histone Deacetylase Inhibitors Research
- Histone Deacetylase Inhibitors Research
- Hemoglobinopathies and Related Disorders
- Hematological disorders and diagnostics
- Hematological disorders and diagnostics
- Childhood Cancer Survivors' Quality of Life
- Platelet Disorders and Treatments
- Childhood Cancer Survivors' Quality of Life
- Platelet Disorders and Treatments
- Mast cells and histamine
- Amyloidosis: Diagnosis, Treatment, Outcomes
Keywords (DOAJ)
- leukemia
- lymphoma
- multiple myeloma
- hematologic malignancy
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
The journal's record in other sources:Web of Science MJLDOAJ